EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Global Drugmakers Investment: Global Drugmakers Invest $500 Billion to Enhance U.S. Manufacturing and Research, ETBrandEquity
Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?
Royalty Pharma plc (RPRX) vs. AstraZeneca PLC (AZN): Which Biopharma Model Offers the Better Growth Story?
Will AstraZeneca Have to Pay Medical Expenses for Woman Injured During COVID Vaccine Trial?
Leave no one behind: optimizing kidney protection in type 1 diabetes
Royalty Pharma (RPRX) Q2 2026 Earnings Call Transcript
Mineralys Therapeutics Inc (MLYS) (Q2 2026) Earnings Call Highlights: Strong Cash Position and ...
Beyond the Scalpel: how the PROTEUS trial redefines the role of the radical prostatectomy
AstraZeneca PLC (AZN) vs. Bristol-Myers Squibb Company (BMY): Wall Street Doesn't Buy This Merger Talk
Hedge Funds are Bullish on AstraZeneca PLC (AZN)
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?
Lupin gets FDA nod for hyperkalemia drug
Astrazeneca Plc $AZN Shares Sold by NewEdge Advisors LLC
FY2026 EPS Estimates for Astrazeneca Cut by Erste Group Bank - Daily Political
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer
From RAS inhibitor resistance to rational combination strategies
Can AstraZeneca (AZN) Reach Its $80 Billion Revenue Goal Despite Clinical Setbacks?
Jim Cramer Highlights Pharmaceutical Giants as Non-Tech Innovation Plays Like JNJ and LLY
Lupin Gets FDA Approval for Hyperkalemia Drug | Morningstar
21 New 4-Star Stocks This Week | Morningstar
Global drugmakers invest billions to boost U.S. presence
Fasenra® (benralizumab) now approved in Canada for hypereosinophilic syndrome
Promising Pharmaceutical Stocks To Watch Now - August 10th - Daily Political
FY2027 EPS Estimates for Astrazeneca Reduced by Analyst
Type 2 diabetes prevention across the life course
Sun Pharmaceutical Industries Ltd Futures Share Price & Chart Today | IIFL Capital
Goldman Sachs Sticks to Its Buy Rating for Genmab A/S (0MGB)
Oliver Luxxe Assets LLC Purchases New Position in Astrazeneca Plc $AZN
Beacon Investment Advisory Services Inc. Invests $767,000 in Astrazeneca Plc $AZN
Astrazeneca Plc $AZN Shares Sold by FNY Investment Advisers LLC - Daily Political
Manufacturing Stocks To Follow Today - August 8th - Markets Daily
Gradient Investments LLC Makes New Investment in Astrazeneca Plc $AZN
161,624 Shares in Astrazeneca Plc $AZN Acquired by Professional Advisory Services Inc.
Parallel Advisors LLC Invests $1.72 Million in Astrazeneca Plc $AZN - Zolmax
Parallel Advisors LLC Purchases New Position in Astrazeneca Plc $AZN
AstraZeneca's (AZN) "Sell" Rating Reiterated at Deutsche Bank Aktiengesellschaft - Markets Daily
Chesley Taft & Associates LLC Invests $15.41 Million in Astrazeneca Plc $AZN
Cooper Financial Group Buys New Position in Astrazeneca Plc $AZN
The FTSE 100's close to a record high. Does this mean a stock market crash is coming?
Professional Advisory Services Inc. Buys New Stake in Astrazeneca Plc $AZN - Stock Observer
Community Trust & Investment Co. Makes New $17.27 Million Investment in Astrazeneca Plc $AZN - Daily Political
Exploring PDLIM2 as a prognostic biomarker and therapeutic target in lung adenocarcinoma
AstraZeneca (LSE:AZN) Merger Talk Fades, Is The Stock Undervalued?
Assenagon Asset Management S.A. Buys 422,866 Shares of Astrazeneca Plc $AZN - Markets Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN | Morningstar
Sun Pharmaceutical Industries Ltd Option Chain & Strike Prices | IIFL Capital
AI-based augmentation of oncology clinical trials
The dynamic spectrum of steatotic liver disease: the global perspective
Artificial intelligence in drug discovery - what it is, where we stand and the path forward
North American Morning Briefing: Nasdaq Futures Slip on AI Anxiety | Morningstar
Tlwm Makes New $1.76 Million Investment in Astrazeneca Plc $AZN
AstraZeneca may buck a decade of pharma strategy to buy U.S. scale
180 Wealth Advisors LLC Invests $3.89 Million in Astrazeneca Plc $AZN
High-Stakes 100-Billion-Yuan Mega Investment Gamble Unfolds: What's Next for the Trillion-Scale Economic Bet?
AstraZeneca and Bristol Myers Squibb: No Ongoing Merger Discussions Confirmed, ETPharma
AstraZeneca, Jaguar Land Rover join UK push to lure talent away from US
AstraZeneca's (AZN) "Buy" Rating Reiterated at Jefferies Financial Group - Daily Political
Astrazeneca (NYSE:AZN) Sees Large Volume Increase - Here's What Happened
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - Markets Daily
SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 1-Year High After Analyst Upgrade - Zolmax
AstraZeneca and Bristol Myers Squibb merger talks denied
Astrazeneca Plc (NYSE:AZN) Plans Dividend of GBP 0.80
Exclusive-'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price - Zolmax
Deutsche Bank Aktiengesellschaft Reiterates Sell Rating for AstraZeneca (LON:AZN) - Daily Political
Harvard Student Consultants Log 400 Hours and Party With Snakes
Astrazeneca Plc (AZN) to Issue Dividend of GBP 0.80 on September 8th - Daily Political
SOPHiA GENETICS (NASDAQ:SOPH) Price Target Raised to $9.00 at BTIG Research - Daily Political
Eastern Bank Purchases Shares of 6,092 Astrazeneca Plc $AZN - Daily Political
Integrating clinically actionable biomarkers into bladder cancer care - recommendations from the International Bladder Cancer Group
AstraZeneca-BMY megadeal talk sparks huge market rift
SOPH Stock Heads For Best Day In Over 8 Months - What's Driving Today's Super Rally?
Brokers split on AstraZeneca merger talk as shares recover some ground
Most big businesses bought zero new petrol or diesel cars for their fleets last year, report reveals
SOPHiA GENETICS Collaborates With AstraZeneca To Develop Precision Oncology Companion Diagnostics
Hilltop National Bank Invests $1.44 Million in Astrazeneca Plc $AZN
Pharmaceutical Stocks Worth Watching - August 4th - Daily Political
Hilltop National Bank Buys Shares of 7,577 Astrazeneca Plc $AZN - Stock Observer
Why Did AMZN, SNOW, BMY Stocks Surge To 52-Week Highs Today?
UK's AstraZeneca eyeing $400b merger, report says - World - Chinadaily.com.cn
Navigating evidence-based recommendations for the management of systemic sclerosis
International Business: AstraZeneca shares fall on merger talks
Advances in the treatment of eosinophilic granulomatosis with polyangiitis
European shares start August higher on US-Iran diplomacy hopes
Amazon joins US$3t market cap club as cheaper oil buoys market
The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today
AstraZeneca Stock Plunges 7.7% on Reported $400 Billion Merger Talks
Top Healthcare Analyst: A $400 Billion AstraZeneca-Bristol Myers Deal Could "Cut Costs in a Big Way"
Latest news
Show more
Gold Price Today, August 14: XAU/USD Falls Below $4,350 as Profit-Taking Deepens
KOSPI Rises 2.7% Towards 7,000 as SK Hynix Gains 6% and Kioxia Jumps 7%
SanDisk Stock Jumps Nearly 14% on Bullish 2030 Targets, Lam Research Gains Over 3%
